Answers are grounded in this paper and cite their sources.
Cortical florbetapir uptake is increased in patients with CAA-related ICH relative to those with deep ICH. Although ¹⁸F-florbetapir PET can label vascular β-amyloid and might serve as an outcome marker in future clinical trials, its diagnostic value in acute CAA-related ICH seems limited in clinical practice.
No takes yet. Share an insight, caveat, or question.
Raposo et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: